{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:53:19Z","timestamp":1792785199435,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T00:00:00Z","timestamp":1536710400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007903","name":"Bloodwise","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007903","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research Biomedical Research Center","id":[{"id":"https:\/\/ror.org\/0525ajp52","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["cancercell.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.ccell.2018.08.017","type":"journal-article","created":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T13:57:12Z","timestamp":1539007032000},"page":"596-610.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":191,"title":["Enhanced Anti-lymphoma Activity of CAR19-iNKT Cells Underpinned by Dual CD19 and CD1d Targeting"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2891-5793","authenticated-orcid":false,"given":"Antonia","family":"Rotolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina S.","family":"Caputo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Holubova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoleta","family":"Baxan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Suhail","family":"Chaudhry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Goudevenou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Pitcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyriaki","family":"Petevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Kachramanoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Iles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kikkeri","family":"Naresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Maher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasios","family":"Karadimitris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccell.2018.08.017_bib1","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1089\/hgtb.2013.022","article-title":"Potential limitations of the NSG humanized mouse as a model system to optimize engineered human T\u00a0cell therapy for cancer","volume":"24","author":"Alcantar-Orozco","year":"2013","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.ccell.2018.08.017_bib2","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.4049\/jimmunol.1003615","article-title":"CD1d and CD1c expression in human B cells is regulated by activation and retinoic acid receptor signaling","volume":"186","author":"Allan","year":"2011","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ccell.2018.08.017_bib3","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/gt.2015.4","article-title":"Inclusion of an IgG1-Fc spacer abrogates efficacy of CD19 CAR T\u00a0cells in a xenograft mouse model","volume":"22","author":"Almasbak","year":"2015","journal-title":"Gene Ther."},{"key":"10.1016\/j.ccell.2018.08.017_bib4","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3324\/haematol.2008.001339","article-title":"Adoptive immunotherapy mediated by ex\u00a0vivo expanded natural killer T\u00a0cells against CD1d-expressing lymphoid neoplasms","volume":"94","author":"Bagnara","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.ccell.2018.08.017_bib5","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.immunol.25.022106.141711","article-title":"The biology of NKT cells","volume":"25","author":"Bendelac","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ccell.2018.08.017_bib6","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.immuni.2012.02.008","article-title":"Lipid-antigen presentation by CD1d(+) B cells is essential for the maintenance of invariant natural killer T\u00a0cells","volume":"36","author":"Bosma","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.ccell.2018.08.017_bib7","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/ni1002","article-title":"Mechanism of CD1d-restricted natural killer T\u00a0cell activation during microbial infection","volume":"4","author":"Brigl","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ccell.2018.08.017_bib8","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1084\/jem.188.8.1521","article-title":"CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T\u00a0cells is highly conserved through mammalian evolution","volume":"188","author":"Brossay","year":"1998","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2018.08.017_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrclinonc.2017.128","article-title":"Chimeric antigen receptor T-cell therapies for lymphoma","volume":"15","author":"Brudno","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ccell.2018.08.017_bib10","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1093\/hmg\/ddt171","article-title":"Mechanism of Polycomb recruitment to CpG islands revealed by inherited disease-associated mutation","volume":"22","author":"Caputo","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ccell.2018.08.017_bib11","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1182\/blood-2011-11-389304","article-title":"Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation","volume":"119","author":"Chaidos","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2018.08.017_bib12","first-page":"488","article-title":"Retinoic acid regulates CD1d gene expression at the transcriptional level in human and rodent monocytic cells","volume":"232","author":"Chen","year":"2007","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.ccell.2018.08.017_bib13","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1182\/blood.V88.8.3230.bloodjournal8883230","article-title":"An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin","volume":"88","author":"Cooke","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2018.08.017_bib14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ccell.2018.08.017_bib15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1084\/jem.186.1.109","article-title":"Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8- T\u00a0cells","volume":"186","author":"Exley","year":"1997","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2018.08.017_bib16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1365-2567.2000.00001.x","article-title":"CD1d structure and regulation on human thymocytes, peripheral blood T\u00a0cells, B cells and monocytes","volume":"100","author":"Exley","year":"2000","journal-title":"Immunology"},{"key":"10.1016\/j.ccell.2018.08.017_bib17","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1158\/1078-0432.CCR-16-0600","article-title":"Adoptive transfer of invariant NKT cells as immunotherapy for advanced melanoma: a phase I clinical trial","volume":"23","author":"Exley","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2018.08.017_bib18","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.clim.2011.04.017","article-title":"Developing understanding of the roles of CD1d-restricted T\u00a0cell subsets in cancer: reversing tumor-induced defects","volume":"140","author":"Exley","year":"2011","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.ccell.2018.08.017_bib19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature21405","article-title":"Targeting a CAR to the TRAC locus with CRISPR\/Cas9 enhances tumour rejection","volume":"543","author":"Eyquem","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2018.08.017_bib20","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/sj.leu.2403671","article-title":"CD1d expression on B-precursor acute lymphoblastic leukemia subsets with poor prognosis","volume":"19","author":"Fais","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.ccell.2018.08.017_bib21","doi-asserted-by":"crossref","first-page":"6335","DOI":"10.4049\/jimmunol.1003965","article-title":"IL-15 regulates homeostasis and terminal maturation of NKT cells","volume":"187","author":"Gordy","year":"2011","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ccell.2018.08.017_bib22","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1182\/blood-2016-11-751065","article-title":"Invariant NKT cells contribute to chronic lymphocytic leukemia surveillance and prognosis","volume":"129","author":"Gorini","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2018.08.017_bib23","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1084\/jem.20011786","article-title":"Functionally distinct subsets of CD1d-restricted natural killer T\u00a0cells revealed by CD1d tetramer staining","volume":"195","author":"Gumperz","year":"2002","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2018.08.017_bib24","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1182\/blood-2013-11-541235","article-title":"Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy","volume":"124","author":"Heczey","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2018.08.017_bib25","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1471-4906(02)02323-2","article-title":"Distinct subsets of human Valpha24-invariant NKT cells: cytokine responses and chemokine receptor expression","volume":"23","author":"Kim","year":"2002","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ccell.2018.08.017_bib26","doi-asserted-by":"crossref","first-page":"R36","DOI":"10.1186\/gb-2013-14-4-r36","article-title":"TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions","volume":"14","author":"Kim","year":"2013","journal-title":"Genome Biol."},{"key":"10.1016\/j.ccell.2018.08.017_bib27","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1309\/AJCP2F2DOXOTXHZA","article-title":"The diagnostic value of CD1d expression in a large cohort of patients with B-cell chronic lymphoproliferative disorders","volume":"136","author":"Kotsianidis","year":"2011","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ccell.2018.08.017_bib28","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nprot.2009.22","article-title":"Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors","volume":"4","author":"Kutner","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ccell.2018.08.017_bib29","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1182\/blood-2010-08-303008","article-title":"Low doses of natural killer T\u00a0cells provide protection from acute graft-versus-host disease via an IL-4-dependent mechanism","volume":"117","author":"Leveson-Gower","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2018.08.017_bib30","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1093\/nar\/gkt214","article-title":"The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote","volume":"41","author":"Liao","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ccell.2018.08.017_bib31","doi-asserted-by":"crossref","first-page":"11445","DOI":"10.1073\/pnas.200363097","article-title":"IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice","volume":"97","author":"Marks-Konczalik","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2018.08.017_bib32","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.clml.2017.07.007","article-title":"Chimeric antigen receptor T-cell therapy for chronic lymphocytic leukemia: a narrative review","volume":"17","author":"Mato","year":"2017","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.ccell.2018.08.017_bib33","doi-asserted-by":"crossref","first-page":"e1000402","DOI":"10.1371\/journal.pbio.1000402","article-title":"Innate-like control of human iNKT cell autoreactivity via the hypervariable CDR3beta loop","volume":"8","author":"Matulis","year":"2010","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ccell.2018.08.017_bib34","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.4049\/jimmunol.167.6.3114","article-title":"Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells","volume":"167","author":"Metelitsa","year":"2001","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ccell.2018.08.017_bib35","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2018.08.017_bib36","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1001\/archderm.135.5.546","article-title":"Response of murine and normal human skin to injection of allogeneic blood-derived psoriatic immunocytes: detection of T\u00a0cells expressing receptors typically present on natural killer cells, including CD94, CD158, and CD161","volume":"135","author":"Nickoloff","year":"1999","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.ccell.2018.08.017_bib37","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0198-8859(98)00100-1","article-title":"Activation of human Valpha24 NKT cells by alpha-glycosylceramide in a CD1d-restricted and Valpha24 TCR-mediated manner","volume":"60","author":"Nieda","year":"1999","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.ccell.2018.08.017_bib38","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1056\/NEJMoa1709919","article-title":"Long-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia","volume":"378","author":"Park","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2018.08.017_bib39","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1182\/blood-2014-01-545020","article-title":"A highly compact epitope-based marker\/suicide gene for easier and safer T-cell therapy","volume":"124","author":"Philip","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2018.08.017_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaj2013","article-title":"Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T\u00a0cells","volume":"9","author":"Qasim","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ccell.2018.08.017_bib41","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ccell.2018.08.017_bib42","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/bjh.13976","article-title":"The prospects and promise of chimeric antigen receptor immunotherapy in multiple myeloma","volume":"173","author":"Rotolo","year":"2016","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ccell.2018.08.017_bib43","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/leu.2016.281","article-title":"Pre-transplant donor CD4- invariant NKT cell expansion capacity predicts the occurrence of acute graft-versus-host disease","volume":"31","author":"Rubio","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.ccell.2018.08.017_bib44","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1172\/JCI87366","article-title":"Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies","volume":"126","author":"Ruella","year":"2016","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ccell.2018.08.017_bib45","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev-immunol-032713-120243","article-title":"Biology of CD1- and MR1-restricted T\u00a0cells","volume":"32","author":"Salio","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ccell.2018.08.017_bib46","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1600-065X.2012.01140.x","article-title":"T-cell trafficking in the central nervous system","volume":"248","author":"Sallusto","year":"2012","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ccell.2018.08.017_bib47","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1182\/blood-2014-05-576017","article-title":"CD4+ invariant natural killer T\u00a0cells protect from murine GVHD lethality through expansion of donor CD4+CD25+FoxP3+ regulatory T\u00a0cells","volume":"124","author":"Schneidawind","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2018.08.017_bib48","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1242\/dmm.006668","article-title":"Mouse models of graft-versus-host disease: advances and limitations","volume":"4","author":"Schroeder","year":"2011","journal-title":"Dis. Model Mech."},{"key":"10.1016\/j.ccell.2018.08.017_bib49","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa1708566","article-title":"Chimeric antigen receptor T\u00a0cells in refractory B-cell lymphomas","volume":"377","author":"Schuster","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2018.08.017_bib50","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nrm2763","article-title":"Mechanisms of polycomb gene silencing: knowns and unknowns","volume":"10","author":"Simon","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ccell.2018.08.017_bib51","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1182\/blood-2008-06-161281","article-title":"Regulation of multiple myeloma survival and progression by CD1d","volume":"113","author":"Spanoudakis","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2018.08.017_bib52","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.4049\/jimmunol.164.9.4458","article-title":"Analysis of human V alpha 24+ CD4+ NKT cells activated by alpha-glycosylceramide-pulsed monocyte-derived dendritic cells","volume":"164","author":"Takahashi","year":"2000","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ccell.2018.08.017_bib53","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1172\/JCI83476","article-title":"CD62L+ NKT cells have prolonged persistence and antitumor activity in\u00a0vivo","volume":"126","author":"Tian","year":"2016","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ccell.2018.08.017_bib54","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1182\/blood-2011-10-387969","article-title":"CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results","volume":"119","author":"Till","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2018.08.017_bib55","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nbt.1621","article-title":"Transcript assembly and quantification by RNA-seq reveals unannotated transcripts and isoform switching during cell differentiation","volume":"28","author":"Trapnell","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ccell.2018.08.017_bib56","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftw055","article-title":"Alterations in cellular metabolism modulate CD1d-mediated NKT-cell responses","volume":"74","author":"Webb","year":"2016","journal-title":"Pathog. Dis."},{"key":"10.1016\/j.ccell.2018.08.017_bib57","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1016\/j.ymthe.2017.09.018","article-title":"Targeting of Aberrant alphavbeta6 integrin expression in solid tumors using chimeric antigen receptor-engineered T\u00a0cells","volume":"25","author":"Whilding","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ccell.2018.08.017_bib58","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1172\/JCI32693","article-title":"OX40 ligand expressed by DCs costimulates NKT and CD4+ Th cell antitumor immunity in mice","volume":"117","author":"Zaini","year":"2007","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ccell.2018.08.017_bib59","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ccell.2015.09.004","article-title":"Structural design of engineered costimulation determines tumor rejection kinetics and persistence of CAR T\u00a0cells","volume":"28","author":"Zhao","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2018.08.017_bib60","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1172\/JCI33976","article-title":"OX40 signaling directly triggers the antitumor effects of NKT cells","volume":"117","author":"Zhou","year":"2007","journal-title":"J.\u00a0Clin. Invest."}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610818303775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610818303775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T18:03:57Z","timestamp":1572026637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610818303775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1535610818303775"],"URL":"https:\/\/doi.org\/10.1016\/j.ccell.2018.08.017","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.734190250.793552880","asserted-by":"object"}]},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced Anti-lymphoma Activity of CAR19-iNKT Cells Underpinned by Dual CD19 and CD1d Targeting","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2018.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}